Submissions for variant NM_000271.5(NPC1):c.2524T>C (p.Phe842Leu)

gnomAD frequency: 0.00017  dbSNP: rs190298665

Total submissions: 6

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Eurofins Ntd Llc (ga)	RCV000596349	SCV000704660	uncertain significance	not provided	2016-12-15	criteria provided, single submitter	clinical testing
Invitae	RCV000649025	SCV000770846	pathogenic	Niemann-Pick disease, type C1	2024-01-25	criteria provided, single submitter	clinical testing	This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 842 of the NPC1 protein (p.Phe842Leu). This variant is present in population databases (rs190298665, gnomAD 0.02%). This missense change has been observed in individuals with Niemann-Pick Disease Type C (PMID: 29453517; Invitae). ClinVar contains an entry for this variant (Variation ID: 499258). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPC1 protein function with a positive predictive value of 95%. This variant disrupts the p.Phe842 amino acid residue in NPC1. Other variant(s) that disrupt this residue have been determined to be pathogenic (Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
New York Genome Center	RCV000649025	SCV002099149	uncertain significance	Niemann-Pick disease, type C1	2021-04-02	criteria provided, single submitter	clinical testing	The c.2524T>C, p.Phe842Leu missense variant identified in NPC1 has been reported in trans with a pathogenic variant in a 31-year-old patient with Niemann-Pick disease type C [PMID: 29453517]. This variant has twenty nine heterozygous alleles in the gnomAD v3 database consistent with the carrier frequency and in silico tools predict a deleterious effect. Based on the available evidence, the variant c.2524T>C, p.Phe842Leu in the NPC1gene is classified as a variant of uncertain significance.
Revvity Omics, Revvity	RCV000649025	SCV003816041	uncertain significance	Niemann-Pick disease, type C1	2020-03-12	criteria provided, single submitter	clinical testing
PreventionGenetics, part of Exact Sciences	RCV003952965	SCV004767838	likely pathogenic	NPC1-related condition	2023-12-20	criteria provided, single submitter	clinical testing	The NPC1 c.2524T>C variant is predicted to result in the amino acid substitution p.Phe842Leu. This variant has been reported in the compound heterozygous state in an individual with adult-onset Niemann-Pick disease type C (Zeiger et al. 2018. PubMed ID: 29453517) and was also identified in the analysis of a large sequencing dataset that did not include individuals with Niemann-Pick disease (Wassif et al. 2015. PubMed ID: 25764212). Additionally, this variant was seen in the compound heterozygous state in a patient at PreventionGenetics with biochemical findings that confirmed the diagnosis of Niemann-Pick disease. In summary, we interpret this variant as likely pathogenic.
Natera, Inc.	RCV000649025	SCV001455861	uncertain significance	Niemann-Pick disease, type C1	2020-09-16	no assertion criteria provided	clinical testing